Meet the founder

Marcus D. R. Klarqvist founded Vintergatan Ventures to provide technical leadership and engineering services to healthcare and medtech companies. Through Vintergatan, Marcus has led technical teams from proof-of-concept through production deployment and regulatory submission. The firm's portfolio spans diverse medical AI applications. Each project delivers complete technical implementations: web applications, mobile applications and interfaces, cloud infrastructure, and embedded firmware, with comprehensive documentation for IEC 62304 and ISO 13485 compliance. These systems have achieved FDA clearance, CE marking, and UKCA approval.

Marcus holds a PhD from the University of Cambridge. Prior to founding Vintergatan, he was a founding member of the Machine Learning for Health (ML4H) program at the Broad Institute of MIT and Harvard, where he developed AI systems for clinical applications. His work has processed datasets including 100M+ clinical notes and 10M+ ECGs, resulting in 20+ peer-reviewed publications in journals including Nature Medicine and Nature Genetics. His deep expertise in both AI/ML and healthcare regulatory requirements enables him to deliver systems that are not only technically advanced but also compliant and market-ready.